產(chǎn)品名稱 BIBW 2992 - Afatinib
產(chǎn)品貨號(hào) Axon 1544 CAS [850140-72-6] MF C24H25ClFN5O3MW 485.94 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Second generation tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal receptor 2 (Her2 or ErbB 2) and EGFR (HER1) kinases. An investigational drug for breast cancer as well as other EGFR and Her2 driven cancers such as NSCLC and Head-and-Neck KEYWORDS: BIBW 2992 | supplier | EGFR/HER2 inhibitor | 850140-72-6 | 439081-18-2 |?Afatinib | BIBW2992 | BIBW-2992 | EGFR | ErbB2-HER2 | TKI | breast cancer | epidermal | growft factor
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

BIBW 2992 - Afatinib

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1544

CAS [850140-72-6]

MF C24H25ClFN5O3
MW 485.94

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

BIBW 2992

Description

Second generation tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal receptor 2 (Her2 or ErbB 2) and EGFR (HER1) kinases. An investigational drug for breast cancer as well as other EGFR and Her2 driven cancers such as NSCLC and Head-and-Neck

KEYWORDS: BIBW 2992 | supplier | EGFR/HER2 inhibitor | 850140-72-6 | 439081-18-2 |?Afatinib | BIBW2992 | BIBW-2992 | EGFR | ErbB2-HER2 | TKI | breast cancer | epidermal | growft factor

產(chǎn)品資料